Showing results (81-90 of 201) with videos related to

Sort By:
Pageof 21
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulvaSara Moufarrij, Olga Filippova, Arnaud Da Cruz Paula, et al.
Nucleic Acids Research|January 20, 2025
An integrated approach for the accurate detection of HERV-K HML-2 transcription and protein synthesisCharles Gleason, Sandra N Terry, Matthew M Hernandez, et al.
European Urology|April 23, 2020
Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical CharacteristicsBastien Nguyen, Jose Mauricio Mota, Subhiksha Nandakumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology StudyDmitriy Zamarin, Robert A Burger, Michael W Sill, et al.
Obstetrics and Gynecology|May 7, 2026
Hereditary Breast and Ovarian Cancer: Overview of Gene-Specific Risks and Challenges in Genetics Care DeliveryYing L Liu, Varshini Gali, Melissa K Frey
Cancer Research|December 18, 2021
Targeting Ribonucleotide Reductase Induces Synthetic Lethality in PP2A-Deficient Uterine Serous CarcinomaCaitlin M O'Connor, Sarah E Taylor, Kathryn M Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2026
Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancerJyoti Mayadev, Wei Deng, Hayeon Kim, et al.
Gynecologic Oncology|March 6, 2021
Molecular characterization of high-grade serous ovarian cancers occurring in younger and older womenOlga T Filippova, Pier Selenica, Fresia Pareja, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2022
Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancerStella V Paffenholz, Camilla Salvagno, Yu-Jui Ho, et al.
Pageof 21